secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001193125-22-174803
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences shareholders approve reverse stock split ratio of 1:4 to 1:10
--------------------------------------------------------------------------------

- Reverse stock split authorized by 93.5% of votes cast (25.9M for, 1.7M against).
- Three directors elected: Hilleman, Laghrissi-Thode, Luthringer (each with ~16M for).
- Advisory say-on-pay approved with 17.4M for, 891K against, 9.3M broker non-votes.
- Deloitte & Touche ratified as auditor for FY2022 with 27.1M for, 552K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522174803/0001193125-22-174803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522174803/d315229d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-174803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer